The potential for metabolomics in the study and treatment of major depressive disorder and related conditions

Volume: 17, Issue: 4, Pages: 309 - 322
Published: Apr 2, 2020
Abstract
Introduction Major depressive disorder (MDD) is a common mental disease, associated with a debilitating condition and high prevalence. Although the underlying mechanism of MDD remains to be elucidated, several factors, including social, biological, and psychological factors, have been associated with disease pathogenesis. Metabolomics can provide new insights into the prognosis, treatment response, and related biomarkers associated with MDD at...
Paper Details
Title
The potential for metabolomics in the study and treatment of major depressive disorder and related conditions
Published Date
Apr 2, 2020
Volume
17
Issue
4
Pages
309 - 322
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.